SCHEMBL6993528

SCHEMBL6993528

CCOC(=O)c1ccc(CCC(CNC(=O)OC(C)(C)C)SC(C)=O)s1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SERPINE1 P05121 1/20 0.37
HDAC3 O15379 1/20 0.37
HDAC4 P56524 1/20 0.37
HDAC1 Q13547 1/20 0.37
HDAC6 Q9UBN7 1/20 0.37
SYK P43405 1/20 0.35
MAPT P10636 6/20 0.34
KDM4E B2RXH2 3/20 0.34
NPSR1 Q6W5P4 1/20 0.34
TDP1 Q9NUW8 2/20 0.34
ALDH1A1 P00352 3/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
IDO1 P14902 1/20 0.32
ABCB1 P08183 1/20 0.32
GSK3B P49841 1/20 0.31
P2RY1 P47900 1/20 0.31
PHGDH O43175 1/20 0.31
PCSK9 Q8NBP7 1/20 0.31
ERN1 O75460 1/20 0.31
JAK2 O60674 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7000492 1.00 SERPINE1 (0.37) SERPINE1HDAC3HDAC4HDAC1HDAC6
SCHEMBL6993531 1.00 SERPINE1 (0.37) SERPINE1HDAC3HDAC4HDAC1HDAC6
SCHEMBL7019336 0.91 SERPINE1 (0.37) SERPINE1SYKMAPTNPSR1TDP1
SCHEMBL6996062 0.87 SERPINE1 (0.37) SERPINE1HDAC3HDAC4HDAC1HDAC6
SCHEMBL6986607 0.87 SERPINE1 (0.37) SERPINE1HDAC3HDAC4HDAC1HDAC6
SCHEMBL6986606 0.87 SERPINE1 (0.37) SERPINE1HDAC3HDAC4HDAC1HDAC6
SCHEMBL6989772 0.85 HDAC3 (0.41) SERPINE1HDAC3HDAC4HDAC1HDAC6
SCHEMBL6989769 0.85 HDAC3 (0.41) SERPINE1HDAC3HDAC4HDAC1HDAC6
SCHEMBL6992685 0.85 HDAC3 (0.41) SERPINE1HDAC3HDAC4HDAC1HDAC6
SCHEMBL7001569 0.84 SERPINE1 (0.37) SERPINE1HDAC3HDAC4HDAC1HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0846111-B1 SYNTHESES OF OPTICALLY PURE COMPOUNDS USEFUL AS GARFT INHIBITORS AND THEIR INTERMEDIATES AGOURON PHARMA (US) 2003-08-27 EP disclosed
US-5981748-A Synthesis of optically pure compounds useful as GARFT inhibitors and their intermediates AGOURON PHARMACEUTICALS, INC. (US) 1999-11-09 US disclosed
US-5831100-A Syntheses of optically pure compounds useful as GARFT inhibitors and their intermediates AGOURON PHARMACEUTICALS, INC. (US) 1998-11-03 US disclosed
EP-0846111-A1 SYNTHESES OF OPTICALLY PURE COMPOUNDS USEFUL AS GARFT INHIBITORS AND THEIR INTERMEDIATES AGOURON PHARMACEUTICALS, INC. (US) 1998-06-10 EP disclosed
WO-1996040674-A1 SYNTHESES OF OPTICALLY PURE COMPOUNDS USEFUL AS GARFT INHIBITORS AND THEIR INTERMEDIATES AGOURON PHARMACEUTICALS, INC. (US) 1996-12-19 WO disclosed